The perceived heart risks that torpedoed sales of GlaxoSmithKline Plc’s best-selling diabetes pill Avandia may have been overstated and restrictions on prescribing the drug should be eased, U.S. advisers said.
Micromet Inc. , a 17-year-old biotechnology company with no medicines on the market, is attracting attention from product-hungry drugmakers. The lure: a technology for fighting cancer without using toxic chemicals.
Researchers urged doctors to discuss with patients the benefits of Merck & Co .’s Proscar for preventing prostate cancer, after a study found that prescribing of the product didn’t increase when a 2003 trial showed the medicine wards off tumors.
Pfizer Inc. , the world’s biggest drugmaker, leads a race against three rivals to sell the first new pill in a decade for rheumatoid arthritis, a joint disease treated by injected drugs with $12 billion in annual sales.
Pfizer Inc. ’s experimental pill for rheumatoid arthritis reduced pain and inflammation for 71 percent of patients in a study that may help the company supplant injectable drugs with $12 billion in yearly sales.